Mera Pharmaceuticals, Inc. (MRPI)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 14, 2026
Mera Pharmaceuticals Market Cap
Mera Pharmaceuticals has a market cap or net worth of $537 as of October 16, 2026. It is the 52,527th most valuable company in the world and the 8,561st biggest in the United States. Its market cap has decreased by 99.00% in one year.
Market Cap
537.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,561 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 2, 1993, Mera Pharmaceuticals's market cap has decreased from 1.56M to 537.00, a decrease of -99.97%. That is a compound annual growth rate of -21.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 53.67K | -3.62% |
| Dec 30, 2022 | 55.68K | -50.00% |
| Dec 31, 2021 | 111.36K | -95.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteonomix | 791.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Amarantus BioScience Holdings | 630.00 |
| Alzex Neuropharma | 602.00 |
| Adynxx | 581.00 |
| GlobeImmune | 575.00 |
| Tetra Bio-Pharma | 516.00 |